Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Enke

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Population Studies|November 19, 2011
Those alleged pitfallsS Enke
Population Studies|November 15, 2011
Leibenstein on the benefits and costs of birth control programmesS Enke, H Leibenstein
PET Clinics|March 29, 2023
Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting InterventionsSherly Mosessian, Jessica D Jensen, Aaron S Enke
The British Journal of Radiology|June 28, 2025
New Approaches in Nuclear Medicine TheranosticsJohanna S Enke, Lisa Fenzl, Constantin Lapa, et al.
PET Clinics|July 5, 2024
New PET Tracers for LymphomaJohanna S Enke, Ralph A Bundschuh, Rainer Claus, et al.
Translational Oncology|April 9, 2024
Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportionN G Reitsam, B Grosser, J S Enke, et al.
BMC Cancer|January 12, 2024
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancerJohanna S Enke, Matthias Groß, Bianca Grosser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2026
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapySong Xue, Sabrina Kraus, Johanna S Enke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [<sup>68</sup>Ga]Ga-LNTH-1363S on Image QualityJohanna S Enke, Jan Baessler, Gitasha Chand, et al.
Cancers|February 15, 2022
Radiomics Features of the Spleen as Surrogates for CT-Based Lymphoma Diagnosis and Subtype DifferentiationJohanna S Enke, Jan H Moltz, Melvin D'Anastasi, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Population Studies|November 19, 2011
Those alleged pitfallsS Enke
Population Studies|November 15, 2011
Leibenstein on the benefits and costs of birth control programmesS Enke, H Leibenstein
PET Clinics|March 29, 2023
Current State of Clinical Trials and Regulatory Approvals with Fibroblast Activation Protein Targeting InterventionsSherly Mosessian, Jessica D Jensen, Aaron S Enke
The British Journal of Radiology|June 28, 2025
New Approaches in Nuclear Medicine TheranosticsJohanna S Enke, Lisa Fenzl, Constantin Lapa, et al.
PET Clinics|July 5, 2024
New PET Tracers for LymphomaJohanna S Enke, Ralph A Bundschuh, Rainer Claus, et al.
Translational Oncology|April 9, 2024
Stroma AReactive Invasion Front Areas (SARIFA): a novel histopathologic biomarker in colorectal cancer patients and its association with the luminal tumour proportionN G Reitsam, B Grosser, J S Enke, et al.
BMC Cancer|January 12, 2024
SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancerJohanna S Enke, Matthias Groß, Bianca Grosser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2026
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapySong Xue, Sabrina Kraus, Johanna S Enke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 29, 2026
Mass Dose Effects in FAP-Directed Imaging: Influence of Administered Dose of [<sup>68</sup>Ga]Ga-LNTH-1363S on Image QualityJohanna S Enke, Jan Baessler, Gitasha Chand, et al.
Cancers|February 15, 2022
Radiomics Features of the Spleen as Surrogates for CT-Based Lymphoma Diagnosis and Subtype DifferentiationJohanna S Enke, Jan H Moltz, Melvin D'Anastasi, et al.
Pageof 2